NAS
RVMD icon

Nykredit A/S’s Revolution Medicines RVMD Stock Holding History

Nykredit A/S’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.86M Buy
+52,663
New +$7.69M 0.03% 387

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Nykredit A/S's RVMD Position: Q2 2026 in Review

Nykredit A/S opened a new position in Revolution Medicines (RVMD) in Q2 2026: 52,663 shares worth $9.86M. The stake represents 0.03% of the portfolio and ranks #387 among its holdings.

483 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Nykredit A/S held 52,663 shares of Revolution Medicines worth $9.86M as of Q2 2026.
  • Revolution Medicines was a new Nykredit A/S position in Q2 2026.
  • Revolution Medicines made up 0.03% of Nykredit A/S's portfolio in Q2 2026, its #387 holding.
  • 483 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.